Effect of non-surgical periodontal treatment on short chain fatty acid levels in gingival crevicular fluid of patients with generalized aggressive periodontitis

Journal of Periodontal Research

Volumn 49, Issue 5, 2014, Pages 574-583

  Lu, R ^a   Meng, H ^a   Gao, X ^a   Xu, L ^a   Feng, X ^a  

^a PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

Author keywords

Aggressive periodontitis; Gingival crevicular fluid; Non surgical periodontal treatment; Short chain fatty acids

Indexed keywords

ACETIC ACID; BUTYRIC ACID; FORMIC ACID; FORMIC ACID DERIVATIVE; ISOVALERIC ACID; LACTIC ACID; PROPIONIC ACID; PROPIONIC ACID DERIVATIVE; SUCCINIC ACID; VALERIC ACID DERIVATIVE; VOLATILE FATTY ACID;

ADULT; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; AGGRESSIVE PERIODONTITIS; CAPILLARY ELECTROPHORESIS; CASE CONTROL STUDY; CHEMISTRY; COMPARATIVE STUDY; FEMALE; FOLLOW UP; FUSOBACTERIUM NUCLEATUM; GINGIVITIS; HUMAN; ISOLATION AND PURIFICATION; MALE; METABOLISM; MICROBIOLOGY; PERIODONTIUM; PORPHYROMONAS GINGIVALIS; PREVENTIVE DENTISTRY; PREVOTELLA INTERMEDIA; PROCEDURES; TREPONEMA DENTICOLA; YOUNG ADULT;

ACETIC ACID; ADULT; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; AGGRESSIVE PERIODONTITIS; BUTYRIC ACID; CASE-CONTROL STUDIES; ELECTROPHORESIS, CAPILLARY; FATTY ACIDS, VOLATILE; FEMALE; FOLLOW-UP STUDIES; FORMATES; FUSOBACTERIUM NUCLEATUM; GINGIVAL CREVICULAR FLUID; HUMANS; LACTIC ACID; MALE; PENTANOIC ACIDS; PERIODONTAL DEBRIDEMENT; PERIODONTIUM; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA; PROPIONATES; SUCCINIC ACID; TREPONEMA DENTICOLA; YOUNG ADULT;

EID: 84908571600     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/jre.12137     Document Type: Article

References (45)

1. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
2. Emingil G, Han B, Ozdemir G et al. Effect of azithromycin, as an adjunct to nonsurgical periodontal treatment, on microbiological parameters and gingival crevicular fluid biomarkers in generalized aggressive periodontitis. J Periodontal Res 2012;47:729-739.
3. Kaner D, Bernimoulin JP, Dietrich T, Kleber BM, Friedmann A. Calprotectin levels in gingival crevicular fluid predict disease activity in patients treated for generalized aggressive periodontitis. J Periodontal Res 2011;46:417-426.
4. Liu K, Meng H, Lu R et al. Initial periodontal therapy reduced systemic and local 25-hydroxy vitamin D(3) and interleukin-1beta in patients with aggressive periodontitis. J Periodontol 2010;81:260-266.
5. McOrist AL, Abell GC, Cooke C, Nyland K. Bacterial population dynamics and faecal short-chain fatty acid (SCFA) concentrations in healthy humans. Br J Nutr 2008;100:138-146.
6. Matthews GM, Howarth GS, Butler RN. Short-chain fatty acids induce apoptosis in colon cancer cells associated with changes to intracellular redox state and glucose metabolism. Chemotherapy 2012;58:102-109.
7. Tolhurst G, Heffron H, Lam YS et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 2012;61:364-371.
8. Layden BT, Yalamanchi SK, Wolever TM, Dunaif A, Lowe WL Jr. Negative association of acetate with visceral adipose tissue and insulin levels. Diabetes Metab Syndr Obes 2012;5:49-55.
9. Ou J, DeLany JP, Zhang M, Sharma S, O'Keefe SJ. Association between low colonic short-chain fatty acids and high bile acids in high colon cancer risk populations. Nutr Cancer 2012;64:34-40.
10. Al-Lahham S, Roelofsen H, Rezaee F et al. Propionic acid affects immune status and metabolism in adipose tissue from overweight subjects. Eur J Clin Invest 2011;42:357-364.
11. Tsuda H, Ochiai K, Suzuki N, Otsuka K. Butyrate, a bacterial metabolite, induces apoptosis and autophagic cell death in gingival epithelial cells. J Periodontal Res 2010;45:626-634.
12. Niederman R, Buyle-Bodin Y, Lu BY, Robinson P, Naleway C. Short-chain carboxylic acid concentration in human gingival crevicular fluid. J Dent Res 1997;76:575-579.
13. Qiqiang L, Huanxin M, Xuejun G. Longitudinal study of volatile fatty acids in the gingival crevicular fluid of patients with periodontitis before and after nonsurgical therapy. J Periodontal Res 2012;47:740-749.
14. Takahashi N, Saito K, Schachtele CF, Yamada T. Acid tolerance and acid-neutralizing activity of Porphyromonas gingivalis, Prevotella intermedia and Fusobacterium nucleatum. Oral Microbiol Immunol 1997;12:323-328.
15. Roques CG, El kaddouri S, Barthet P, Duffort JF, Arellano M. Fusobacterium nucleatum involvement in adult periodontitis and possible modification of strain classification. J Periodontol 2000; 71: 1144-1150.
16. Huang CB, Alimova Y, Myers TM, Ebersole JL. Short- and medium-chain fatty acids exhibit antimicrobial activity for oral microorganisms. Arch Oral Biol 2011;56:650-654.
17. Downes J, Hooper SJ, Wilson MJ, Wade WG. Prevotella histicola sp. nov., isolated from the human oral cavity. Int J Syst Evol Microbiol 2008;58:1788-1791.
18. Takigawa S, Sugano N, Nishihara R et al. The effect of butyric acid on adhesion molecule expression by human gingival epithelial cells. J Periodontal Res 2008;43:386-390.
19. Vinolo MA, Hatanaka E, Lambertucci RH, Newsholme P, Curi R. Effects of short chain fatty acids on effector mechanisms of neutrophils. Cell Biochem Funct 2009;27:48-55.
20. Vinolo MA, Rodrigues HG, Hatanaka E, Sato FT, Sampaio SC, Curi R. Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J Nutr Biochem 2011;22:849-855.
21. Abe K. Butyric acid induces apoptosis in both human monocytes and lymphocytes equivalently. J Oral Sci 2012;54:7-14.
22. Chang MC, Tsai YL, Chen YW et al. Butyrate induces reactive oxygen species production and affects cell cycle progression in human gingival fibroblasts. J Periodontal Res 2013;48:66-73.
23. Imai K, Ochiai K, Okamoto T. Reactivation of latent HIV-1 infection by the periodontopathic bacterium Porphyromonas gingivalis involves histone modification. J Immunol 2009;182:3688-3695.
24. Eftimiadi C, Stashenko P, Tonetti M et al. Divergent effect of the anaerobic bacteria by-product butyric acid on the immune response: suppression of T-lymphocyte proliferation and stimulation of interleukin-1 beta production. Oral Microbiol Immunol 1991;6:17-23.
25. Mazza JE, Newman MG, Sims TN. Clinical and antimicrobial effect of stannous fluoride on periodontitis. J Clin Periodontol 1981;8:203-212.
26. Silness J, Löe H. Periodontal disease in pregnancy. Ii. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
27. Ashimoto A, Chen C, Bakker I, Slots J. Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions. Oral Microbiol Immunol 1996;11:266-273.
28. Jovetic S, Feroggio M, Marinelli F, Lancini G. Factors influencing cell fatty acid composition and A40926 antibiotic complex production in Nonomuraea sp. ATCC 39727. J Ind Microbiol Biotechnol 2008;35:1131-1138.
29. Hughes FJ, Syed M, Koshy B et al. Prognostic factors in the treatment of generalized aggressive periodontitis: I. Clinical features and initial outcome. J Clin Periodontol 2006;33:663-670.
30. Haffajee AD, Teles RP, Socransky SS. The effect of periodontal therapy on the composition of the subgingival microbiota. Periodontol 2000 2006;42:219-258.
31. Armitage GC. Analysis of gingival crevice fluid and risk of progression of periodontitis. Periodontol 2000 2004;34:109-119.
32. Persson GR, Page RC. Effect of sampling time and repetition on gingival crevicular fluid and aspartate aminotransferase activity. J Periodontal Res 1990;25:236-242.
33. Guentsch A, Kramesberger M, Sroka A, Pfister W, Potempa J, Eick S. Comparison of gingival crevicular fluid sampling methods in patients with severe chronic periodontitis. J Periodontol 2011;82:1051-1060.
34. Feng X, Zhang L, Xu L et al. Detection of 8 periodontal microorganisms and distribution of Porphyromonas gingivalis fimA genotypes in Chinese patients with aggressive periodontitis. J Periodontol 2013; doi:10.1902/jop.2013.120677.
35. Drisko CH. Nonsurgical periodontal therapy. Periodontol 2000 2001;25:77-88.
36. Kolenbrander PE, Andersen RN, Blehert DS, Egland PG, Foster JS, Palmer RJ Jr. Communication among oral bacteria. Microbiol Mol Biol Rev 2002; 66: 486-505, table of contents.
37. Ohta H, Gottschal JC, Fukui K, Kato K. Aspartate and asparagine as electron acceptors for Wolinella recta. Oral Microbiol Immunol 1991;6:76-80.
38. Grenier D. Nutritional interactions between two suspected periodontopathogens, Treponema denticola and Porphyromonas gingivalis. Infect Immun 1992;60:5298-5301.
39. Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987;28:1221-1227.
40. Canani RB, Costanzo MD, Leone L, Pedata M, Meli R, Calignano A. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol 2011;17:1519-1528.
41. Nilsson U, Johansson M, Nilsson A, Bjorck I, Nyman M. Dietary supplementation with beta-glucan enriched oat bran increases faecal concentration of carboxylic acids in healthy subjects. Eur J Clin Nutr 2008;62:978-984.
42. Jakobsdottir G, Bjerregaard JH, Skovbjerg H, Nyman M. Fasting serum concentration of short-chain fatty acids in subjects with microscopic colitis and celiac disease: no difference compared with controls, but between genders. Scand J Gastroenterol 2013;48:696-701.
43. Pollanen MT, Overman DO, Salonen JI. Bacterial metabolites sodium butyrate and propionate inhibit epithelial cell growth in vitro. J Periodontal Res 1997;32:326-334.
44. Mirmonsef P, Zariffard MR, Gilbert D, Makinde H, Landay AL, Spear GT. Short-chain fatty acids induce pro-inflammatory cytokine production alone and in combination with toll-like receptor ligands. Am J Reprod Immunol 2012;67:391-400.
45. Vinolo MA, Rodrigues HG, Hatanaka E, Hebeda CB, Farsky SH, Curi R. Short-chain fatty acids stimulate the migration of neutrophils to inflammatory sites. Clin Sci (Lond) 2009;117:331-338.